Herbert DuPont
教授
Department of Internal Medicine
McGovern Medical School, The University of Texas Health Science Center at Houston;Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston;Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston
关注
立即认领
分享
关注
立即认领
分享
基本信息
浏览量:6
职业迁徙
个人简介
Dr. DuPont’s major research goals are to define the epidemiology, immunology, genetic resistance, clinical features, control, prevention and therapy of enteric infectious diseases. Laboratory techniques and procedures are typically developed in Houston and taken to the field in an international setting.
Four lines of research are currently being conducted by Dr. DuPont and his colleagues. The first is a study of the pathogenesis and epidemiology of diarrhea caused by definable enteric pathogens including enterotoxigenic Escherichia coli (ETEC), enteroaggregative E. coli and norovirus. Molecular typing for epidemiologic studies and novel detection methods including Real-time PCR laboratory methods are being performed in Houston to define microbial virulence genes. Secondly, this group is looking at the host genetics and susceptibility to travelers’ diarrhea and post- infectious irritable bowel syndrome (PI-IBS) with a focus on inflammatory cytokine polymorphisms. Thirdly, clinical trials with novel compounds to prevent and treat travelers’ diarrhea are being carried out. Currently, the group is evaluating a nonabsorbed rifamycin derivative, rifaximin in the prevention and treatment of acute bacterial diarrhea. Finally, this group is working with new vaccines to prevent bacterial and viral diarrhea. The group just completed an international field trial demonstrating a high degree of effectiveness in preventing travelers’ diarrhea and ETEC diarrhea through administration of a transcutaneously applied patch ETEC vaccine developed by IOMAI Corporation. Future clinical studies of safety, immunogenicity and efficacy with this patch vaccine are being planned.
研究兴趣
论文共 490 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
引用1浏览0WOSSCIENCE引用
1
0
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): 2645-2645
引用1浏览0引用
1
0
Yinghong Wang, Krishnavathana Varatharajalu,Malek Shatila, Shu-En Shen, Mary Herrera, Elizabeth Letona, Xin S. Wang,Anusha Thomas,Zhi-Dong Jiang,Herbert DuPont
American Journal of Gastroenterologyno. 10 (2023): S170-S171
Journal of Parkinson's diseaseno. 4 (2023): 501-513
Karen J. Vigil,Herbert L. DuPont
Schlossberg's Clinical Infectious Diseasepp.813-816, (2021)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn